Creo Medical Group PLC (CREO)

Currency in GBP
14.00
+0.50(+3.70%)
Closed·
CREO Scorecard
Full Analysis
Quickly burning through cash
CREO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
13.7514.50
52 wk Range
9.2237.00
Key Statistics
Bid/Ask
11.50 / 14.50
Prev. Close
13.5
Open
13.94
Day's Range
13.75-14.5
52 wk Range
9.22-37
Volume
1.75M
Average Volume (3m)
1.58M
1-Year Change
-57.48%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
CREO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
70.67
Upside
+404.76%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Creo Medical Group PLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Sell
Moving Averages
Buy

Creo Medical Group PLC Company Profile

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a microwave ablation device designed for soft tissue ablation; and SpydrBlade Flex, a multi-modal endoscopic scissor-type device. In addition, it provides endotherapy accessories comprising injection needles, haemostatic clips, snares, and forceps, as well as other products for gastroenterology, pulmonology, and urology. Further, the company offers products for diagnostic, therapeutic, and hygiene purposes. Creo Medical Group PLC was founded in 2003 and is headquartered in Chepstow, the United Kingdom.

Compare CREO to Peers and Sector

Metrics to compare
CREO
Peers
Sector
Relationship
P/E Ratio
−2.1x−3.4x−0.5x
PEG Ratio
0.170.010.00
Price/Book
1.4x1.6x2.6x
Price / LTM Sales
14.6x2.7x3.2x
Upside (Analyst Target)
400.0%39.5%42.7%
Fair Value Upside
Unlock17.1%5.8%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 70.67
(+404.76% Upside)

Earnings

Latest Release
May 19, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

CREO Income Statement

People Also Watch

5,040.0
RKT
-0.04%
505.50
QQ
-0.20%
111.05
TW
-0.40%
1,044.00
BAB
-0.57%
34.95
AVCT
+2.79%

FAQ

What Stock Exchange Does Creo Medical Trade On?

Creo Medical is listed and trades on the London Stock Exchange stock exchange.

What Is the Stock Symbol for Creo Medical?

The stock symbol for Creo Medical is "CREO."

What Is the Creo Medical Market Cap?

As of today, Creo Medical market cap is 56.35M.

What Is Creo Medical's Earnings Per Share (TTM)?

The Creo Medical EPS (TTM) is -0.08.

When Is the Next Creo Medical Earnings Date?

Creo Medical will release its next earnings report on 05 Oct 2025.

From a Technical Analysis Perspective, Is CREO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Creo Medical Stock Split?

Creo Medical has split 2 times.

How Many Employees Does Creo Medical Have?

Creo Medical has 129 employees.

What is the current trading status of Creo Medical (CREO)?

As of 23 Jul 2025, Creo Medical (CREO) is trading at a price of 14.00, with a previous close of 13.50. The stock has fluctuated within a day range of 13.75 to 14.50, while its 52-week range spans from 9.22 to 37.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.